Nls Pharmaceutics Ag
(NASDAQ) NLSP
Nls Pharmaceutics Ag Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$4.21M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NLSP News
NLSP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nls Pharmaceutics Ag
Industry
Pharmaceuticals
Sector
Health CareEmployees
3
CEO
Ronen Twito
Website
www.nlspharma.comHeadquarters
Zurich, 8058, CH
NLSP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-1%
Return on Capital
-1%
Return on Assets
-50%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$3.32K
Operating Income
$4.38M
EBITDA
$3.63M
Operating Cash Flow
$4.27M
Capital Expenditure
$3.92K
Free Cash Flow
$4.27M
Cash & ST Invst.
$1.67M
Total Debt
$0.00
Nls Pharmaceutics Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.99K
+65.2%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
6
N/A
Net Income
$2.22M
+70.8%
EBITDA
$2.22M
+70.6%
Quarterly Fundamentals
Net Cash
$3.07M
+86.0%
Accounts Receivable
$536.69K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-49.93%
N/A
Return on Invested Capital
-1.42%
N/A
Free Cash Flow
$2.07M
+71.6%
Operating Cash Flow
$2.07M
+71.6%